Towards improved diagnosis: radiomics and quantitative biomarkers in 18 F-PSMA-1007 and 18 F-fluorocholine PET/CT for prostate cancer recurrence.
Panagiotidis E, Andreou S, Paschali A, Angeioplasti K, Vlontzou E, Kalathas T, Pipintakou A, Fothiadaki A, Makridou A, Chatzimarkou M, Papanastasiou E, Datseris I, Chatzipavlidou V.
Panagiotidis E, et al. Among authors: papanastasiou e.
Nucl Med Commun. 2024 Sep 1;45(9):796-803. doi: 10.1097/MNM.0000000000001867. Epub 2024 Jun 3.
Nucl Med Commun. 2024.
PMID: 38832429
Clinical Trial.